ArticleBritish journal of cancer2020

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.

Peter Makhov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.